1.
Mirminachi B, Mohammadi Z, Merat S, Neishabouri A, Sharifi AH, Alavian SH, et al. Update on the prevalence of hepatitis c virus infection among iranian general population: A systematic review and meta-analysis. Hepat Mon. 2017;17(2). e42291.
2.
Merat S, Rezvan H, Nouraie M, Jamali A, Assari S, Abolghasemi H, et al. The prevalence of hepatitis B surface antigen and anti-hepatitis B core antibody in Iran: a population-based study. Arch Iran Med. 2009;12(3):225-31. [PubMed: 19400598].
3.
Ziaee M, Ebrahimzadeh A, Azarkar Z, Namaei MH, Saburi A, Fereidouni M, et al. Seroprevalence and Risk Factors for Hepatitis B in an Adult Population: The First Report from Birjand, South Khorasan, Iran. Hepat Mon. 2016;16(9). e36452. doi: 10.5812/hepatmon.36452. [PubMed: 27822260].
4.
Ziaee M, Javanmard D, Sharifzadeh G, Hasan Namaei M, Azarkar G. Genotyping and Mutation Pattern in the Overlapping MHR Region of HBV Isolates in Southern Khorasan, Eastern Iran. Hepat Mon. 2016;16(10). e37806. doi: 10.5812/hepatmon.37806. [PubMed: 27882062].
5.
Marinho RT, Barreira DP. Hepatitis C, stigma and cure. World J Gastroenterol. 2013;19(40):6703-9. doi: 10.3748/wjg.v19.i40.6703. [PubMed: 24187444].
6.
Harris M. Injecting, infection, illness: abjection and hepatitis C stigma. Body Soci. 2009;15(4):33-51.
7.
Rafique I, Saqib M, Siddiqui S, Munir MA, Qureshi H, Javed N, et al. Experiences of stigma among hepatitis B and C patients in Rawalpindi and Islamabad, Pakistan/Expériences de stigmatisation chez des patients atteints d'hépatite B et C à Rawalpindi et Islamabad (Pakistan). East Mediterran Health J. 2014;20(12):796.
8.
Drazic YN, Caltabiano ML. Chronic hepatitis B and C: Exploring perceived stigma, disease information, and health-related quality of life. Nurs Health Sci. 2013;15(2):172-8. doi: 10.1111/nhs.12009. [PubMed: 23171324].
9.
Treloar C, Rance J, Backmund M. Understanding barriers to hepatitis C virus care and stigmatization from a social perspective. Clin Infect Dis. 2013;57 Suppl 2:S51-5. doi: 10.1093/cid/cit263. [PubMed: 23884066].
10.
Cotler SJ, Cotler S, Xie H, Luc BJ, Layden TJ, Wong SS. Characterizing hepatitis B stigma in Chinese immigrants. J Viral Hepat. 2012;19(2):147-52. doi: 10.1111/j.1365-2893.2011.01462.x. [PubMed: 22239504].
11.
Li D, Tang T, Patterson M, Ho M, Heathcote J, Shah H. The impact of hepatitis B knowledge and stigma on screening in Canadian Chinese persons. Can J Gastroenterol. 2012;26(9):597-602. [PubMed: 22993729].
12.
Mahendra VS, Gilborn L, Bharat S, Mudoi R, Gupta I, George B, et al. Understanding and measuring AIDS-related settings: A developing country perspective. SAHARA-J: J Soci Aspect HIV/AIDS. 2007;4(2):616-25.
13.
Abedi F, Akbari MR, Monzavi SM. Evaluation of stigma toward HIV virus carriers in medical students. Mashhad J Med Sci. 2014;17:125-7.
14.
Holzemer WL, Uys LR, Chirwa ML, Greeff M, Makoae LN, Kohi TW, et al. Validation of the HIV/AIDS Stigma Instrument - PLWA (HASI-P). AIDS Care. 2007;19(8):1002-12. doi: 10.1080/09540120701245999. [PubMed: 17851997].
15.
Uys LR, Holzemer WL, Chirwa ML, Dlamini PS, Greeff M, Kohi TW, et al. The development and validation of the HIV/AIDS Stigma Instrument - Nurse (HASI-N). AIDS Care. 2009;21(2):150-9. doi: 10.1080/09540120801982889. [PubMed: 19229683].
16.
Kalichman SC, Simbayi LC, Jooste S, Toefy Y, Cain D, Cherry C, et al. Development of a brief scale to measure AIDS-related stigma in South Africa. AIDS Behav. 2005;9(2):135-43. doi: 10.1007/s10461-005-3895-x. [PubMed: 15933833].
17.
Fife BL, Wright ER. The dimensionality of stigma: a comparison of its impact on the self of persons with HIV/AIDS and cancer. J Health Soc Behav. 2000;41(1):50-67. [PubMed: 10750322].
18.
Andrewin A, Chien LY. Stigmatization of patients with HIV/AIDS among doctors and nurses in Belize. AIDS Patient Care STDS. 2008;22(11):897-906. doi: 10.1089/apc.2007.0219. [PubMed: 19025484].
19.
van de Mortel TF. Health care workers' knowledge of hepatitis C and attitudes towards patients with hepatitis C: a pilot study. Aust J Adv Nurs. 2002;20(1):13-9. [PubMed: 12405278].
LEAVE A COMMENT HERE: